4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001415889-24-029631
PRESIDENT AND CEO sold 24,660 shares at $8.28 ($204,214)
- PRESIDENT AND CEO acquired 67,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chacko Jacob PRESIDENT AND CEO | 2024-12-15 | Option exercise | +67,000 | 803,308 | D | ||
| Chacko Jacob PRESIDENT AND CEO | 2024-12-16 | Sale | −24,660 | $8.28 | $204,214 | 778,648 | D |
| Derivatives | |||||||
| Chacko Jacob PRESIDENT AND CEO | 2024-12-15 | Option exercise · Restricted Stock Unit | −16,667 | 0 | D | ||
| Chacko Jacob PRESIDENT AND CEO | 2024-12-15 | Option exercise · Restricted Stock Unit | −22,000 | 22,000 | D | ||
| Chacko Jacob PRESIDENT AND CEO | 2024-12-15 | Option exercise · Restricted Stock Unit | −28,333 | 56,667 | D | ||
| Open-market sales · 24,660 sh · avg $8.28 · $204,214 | |||||||
Loading xslF345X05/form4-12172024_101258.xml…